ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the “Company”), today announced it will present updated data from a Phase 1/2a trial of MP0533, a novel, multispecific T cell engager for acute myeloid leukemia (AML) patients, in a poster at the ...

Dosimetry portfolio strengthened with Medical Imaging QA and AI validation Louvain-la-Neuve, Belgium, 03 November 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a world-leading provider of quality assurance (QA) solutions, today announces the acquisition of PhantomX GmbH, expanding IBA’s portfolio in healthcare diagnostics and therapeutic systems enabling artificial intelligence (AI) quality assurance. Founded in 2018 by Dr. Paul Jahnke and Dr. Fe ...

Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025. During the week of 27 October up to and including 31 October 2025 a total of 102.003 shares were repurchased at an average price of €17.6450 for a total amount of €1,799,838.05 To date, the total consideration for shares repurchased amounts to 420,203 shares representing 72.40% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of the progress of ...

合作概述 - Ensurge与康宁公司宣布达成一系列协议 共同开发Ensurge的超高性能固态微型电池 [1] - 协议为两家公司整合康宁的Ribbon Ceramic材料及工艺技术与Ensurge成熟的固态微型电池架构建立了框架 [2] - 合作旨在推出超高能量密度的产品线扩展 以商业化用于消费电子、医疗、工业和国防领域的大批量应用的电池 [2] 合作战略意义 - 合作代表了Ensurge的一个重要战略里程碑 [3] - 将康宁的材料科学领导力应用于Ensurge的固态微型电池平台 为下一代智能设备的变革性进步奠定基础 [3] - 两家公司共同致力于卓越的创新和制造 [3] Ensurge公司背景 - 公司是固态微型电池技术领域的全球领导者 总部位于加利福尼亚州圣何塞 [1][4] - 公司拥有世界一流的专家团队 开创了在高精度卷对卷生产线上生产的薄膜电池 [4] - 其创新技术为消费电子、医疗和工业市场中受外形尺寸限制的应用带来了新的可能性 [4] - 公司与全球领先客户合作 加速其人工智能驱动产品上市 并在奥斯陆证券交易所上市 [4] 康宁公司背景 - 康宁公司是材料科学领域的世界领先创新者之一 拥有170年的历史 [5] - 公司在玻璃科学、陶瓷科学和光学物理方面拥有无与伦比的专长 并具备深厚的制造和工程能力 [5] - 公司通过持续研发投资 材料与工艺创新的独特组合 以及与行业全球领先客户的深度信任关系取得成功 [5] - 其市场涵盖光通信、移动消费电子、显示、汽车、太阳能、半导体和生命科学 [5]

Oslo, Norway, 3 November 2025 Ensurge Micropower ASA ("Ensurge" or the "Company") today announces that the Company has entered into a set of agreements with Corning Incorporated (“Corning”), one of the world’s leading innovators in glass, ceramics, and materials science, to jointly develop ultra-high performance solid-state microbatteries based on Ensurge’s platform. Ensurge and Corning have entered into a joint development agreement to establish a framework and joint development program for the two compan ...

公司战略与人事任命 - 法拉第未来宣布与理查德·尼克松基金会董事、美国第37任总统理查德·尼克松的孙子Chris Nixon Cox达成全球战略顾问协议 [1] - Chris Nixon Cox将担任全球投资者关系、政府事务和产业合作的高级顾问，以支持公司加速国际化部署“EAI + Crypto”双飞轮双桥战略 [1] - 在该职位上，Chris Nixon Cox将为公司引荐潜在全球战略投资者、加强政府沟通并扩大跨境产业合作 [2] - Chris Nixon Cox还将加入公司计划成立的FFAI全球战略顾问委员会 [2][11] 战略重点与高管观点 - 公司创始人兼全球首席执行官YT Jia表示，加速“EAI + Crypto”双飞轮双桥战略的全球部署是当前的重中之重，加强顶级投资者渠道、政府关系和国际产业合作至关重要 [3] - Chris Nixon Cox认为其在全球资本市场和可持续技术方面的经验有助于推动公司在此关键阶段的战略增长 [3] - YT Jia指出，Chris Nixon Cox在资本市场、公共政策和监管事务方面的跨行业影响力与专业知识，对公司国际扩张和AI驱动转型的拐点极具价值 [3] 公司背景与业务介绍 - 法拉第未来是一家总部位于加利福尼亚的全球共享智能电动移动生态系统公司 [5] - 公司成立于2014年，旨在通过打造以用户为中心、技术优先的智能驾驶体验来颠覆汽车行业 [5] - 公司旗舰车型FF91体现了其对豪华、创新和性能的愿景 [5] - 公司的FX战略旨在推出配备与FF91类似先进豪华技术的大规模生产车型，以中低价格区间瞄准更广阔的市场 [5]

公司战略与合作 - 公司与美国前总统理查德·尼克松之孙、尼克松基金会董事会成员克里斯·尼克松·考克斯正式签署战略咨询协议，以加速“EAI + Crypto”双飞轮双桥战略的落地 [2] - 足球巨星安德烈斯·伊涅斯塔成为FX Super One的首位全球车主及公司开发者共创官，此次合作体现了全球体育传奇对公司及产品的信任与认可 [8] - 公司中东子公司收到了首笔以加密货币支付的FX Super One定金，进一步验证了Web2 + Web3元化学的巨大价值和能量 [9] 产品与技术进展 - 针对旗舰产品Super One最受期待的功能EAI FACE生产版的软硬件升级和集成工作正在进行中，升级后的产品将为用户带来更具变革性的体验 [5] - 针对计划在美国市场首次亮相的FX 4车型，公司调整了发布策略，其后部设计渲染图计划在11月洛杉矶车展期间展示 [10] 资本市场与投资者关系 - 全球资产管理巨头Vanguard第三季度13G文件显示，其持有约710万股FFAI股票，较第二季度末增长36% [3][14] - 公司与合作伙伴Qualigen团队共同参加了在纽约市举行的ThinkEquity Conference，会见了超过30位投资者，受到华尔街及更广泛资本市场的广泛关注 [7] - 公司团队正积极准备季度财务报告和财报电话会议，预计将按时提交并在电话会中全面介绍FX的最新进展 [6] 市场销售与订单情况 - 继FX Super One中东最终发布会后，公司与三家B2B合作伙伴签约，并收到了总计超过200辆FX Super One的不可退还定金及不具约束力的预订单，超出了既定初始目标 [4][14] - 公司全球总裁Jerry Wang在第三届巴哈马年度峰会上就FF和FX发表了重要演讲，获得了高度积极的反馈 [6]

— HUTCHMED unveils its innovative ATTC platform, potentially providing precision oncology with synergistic dual-mechanism of action — — Lead candidate HMPL-A251 harnesses a selective PI3K/PIKK inhibitor payload, demonstrating promising preclinical efficacy and safety — — Progress in global and China trials, including FRUSICA-2, SANOVO, surufatinib’s PDAC and fanregratinib’s IHCC studies, advances HUTCHMED’s late-stage pipeline — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 02, 2025 (GLOBE NEWSWIRE) - ...

HAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE) -- Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”) platform, today announced that it will provide an update on the six treated patients from Cohort 1 of its Phase 1b/2a Clinical Study of BB-301 being investigated for the treatment of Oculopharyngeal Muscular ...

Underground core drilling at Tomingley is focused on defining extensions to resources as well as improving confidence of Inferred Resources at McLeans and the Western Monzodiorite domain at Roswell. Both McLeans and the Western Monzodiorite are immediately adjacent to existing underground infrastructure. Underground drilling comprising of 9 diamond holes for a total of 3,247 metres was completed to improve the confidence of the Inferred Resource at McLeans. This drilling discovered a second andesite with s ...